Literature DB >> 15757755

Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity.

Jing-Shi Zhang1, Feng Liu, Leaf Huang.   

Abstract

Inflammatory toxicity represents a typical toxicity associated with systemic administration of cationic liposome/DNA complex (lipoplex). Collected information indicates that the lipoplex gene delivery system mediates an uptake of plasmid DNA by the liver, mainly by Kupffer cells, in which a large amount of cytokine is produced. Therefore, many efforts have been made to overcome this problem. Previous reports by our laboratory demonstrated that sequential injection of cationic liposome and DNA could dramatically decrease the toxicity. In comparison with lipoplex injection, this method significantly suppresses the uptake of DNA by the liver. Opsonization effect in the stimulation of Kupffer cell uptake is proposed as an explanation for the differences in the pharmacokinetic properties of plasmid DNA after lipoplex injection and sequential injection. In this review, we cover the current understanding of the mechanisms underlying inflammatory toxicity and the several attempts to overcome this toxicity. The mechanism related to the pharmacokinetic properties of the lipoplex is focused on here for discussion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15757755     DOI: 10.1016/j.addr.2004.12.004

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  43 in total

1.  Transient depletion of kupffer cells leads to enhanced transgene expression in rat liver following retrograde intrabiliary infusion of plasmid DNA and DNA nanoparticles.

Authors:  Hui Dai; Xuan Jiang; Kam W Leong; Hai-Quan Mao
Journal:  Hum Gene Ther       Date:  2011-03-04       Impact factor: 5.695

2.  Multiplexed nanoflares: mRNA detection in live cells.

Authors:  Andrew E Prigodich; Pratik S Randeria; William E Briley; Nathaniel J Kim; Weston L Daniel; David A Giljohann; Chad A Mirkin
Journal:  Anal Chem       Date:  2012-01-30       Impact factor: 6.986

Review 3.  Lipid-based nanoparticles for nucleic acid delivery.

Authors:  Weijun Li; Francis C Szoka
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 4.  Strategies to improve drug delivery across the blood-brain barrier.

Authors:  Albertus G de Boer; Pieter J Gaillard
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 5.  Biological gene delivery vehicles: beyond viral vectors.

Authors:  Yiqi Seow; Matthew J Wood
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

6.  The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

Authors:  Mukaddes Izci; Christy Maksoudian; Bella B Manshian; Stefaan J Soenen
Journal:  Chem Rev       Date:  2021-01-14       Impact factor: 60.622

Review 7.  Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.

Authors:  Dhruvitkumar S Sutaria; Mohamed Badawi; Mitch A Phelps; Thomas D Schmittgen
Journal:  Pharm Res       Date:  2017-03-17       Impact factor: 4.200

8.  Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides.

Authors:  Hyunmin Kang; Robert DeLong; Michael H Fisher; Rudolph L Juliano
Journal:  Pharm Res       Date:  2005-10-01       Impact factor: 4.200

Review 9.  Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.

Authors:  Hui Yi Xue; Shimeng Liu; Ho Lun Wong
Journal:  Nanomedicine (Lond)       Date:  2014-02       Impact factor: 5.307

10.  Large anti-HER2/neu liposomes for potential targeted intraperitoneal therapy of micrometastatic cancer.

Authors:  Stavroula Sofou; Richard Enmon; Stig Palm; Barry Kappel; Pat Zanzonico; Michael R McDevitt; David A Scheinberg; George Sgouros
Journal:  J Liposome Res       Date:  2010-01-13       Impact factor: 3.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.